PLUS THERAPEUTICS: Licenses Novel Oncology Platform

Press/Media: Press / Media

PeriodMay 12 2020

Media coverage

1

Media coverage

  • TitlePLUS THERAPEUTICS: Licenses Novel Oncology Platform
    Media name/outletTroubled Company Reporter
    CountryUnited States
    Date5/12/20
    PersonsAndrew Brenner